456 related articles for article (PubMed ID: 24968045)
21. Multidrug resistant Mycobacterium leprae from patients with leprosy.
Maeda S; Matsuoka M; Nakata N; Kai M; Maeda Y; Hashimoto K; Kimura H; Kobayashi K; Kashiwabara Y
Antimicrob Agents Chemother; 2001 Dec; 45(12):3635-9. PubMed ID: 11709358
[TBL] [Abstract][Full Text] [Related]
22. Investigating drug resistance of Mycobacterium leprae in the Comoros: an observational deep-sequencing study.
Marijke Braet S; Jouet A; Aubry A; Van Dyck-Lippens M; Lenoir E; Assoumani Y; Baco A; Mzembaba A; Cambau E; Vasconcellos SEG; Rigouts L; Suffys PN; Hasker E; Supply P; de Jong BC
Lancet Microbe; 2022 Sep; 3(9):e693-e700. PubMed ID: 35850123
[TBL] [Abstract][Full Text] [Related]
23. Evidence for
Mahajan NP; Lavania M; Singh I; Nashi S; Preethish-Kumar V; Vengalil S; Polavarapu K; Pradeep-Chandra-Reddy C; Keerthipriya M; Mahadevan A; Yasha TC; Nandeesh BN; Gnanakumar K; Parry GJ; Sengupta U; Nalini A
Am J Trop Med Hyg; 2020 Mar; 102(3):547-552. PubMed ID: 31933458
[TBL] [Abstract][Full Text] [Related]
24. [Multi-drug resistant Mycobacterium leprae from patients with leprosy].
Maeda S
Nihon Hansenbyo Gakkai Zasshi; 2004 Sep; 73(3):227-33. PubMed ID: 15508725
[TBL] [Abstract][Full Text] [Related]
25. Prospective study on antimicrobial resistance in leprosy cases diagnosed in France from 2001 to 2015.
Chauffour A; Lecorche E; Reibel F; Mougari F; Raskine L; Aubry A; Jarlier V; Cambau E;
Clin Microbiol Infect; 2018 Nov; 24(11):1213.e5-1213.e8. PubMed ID: 29906598
[TBL] [Abstract][Full Text] [Related]
26. Drug susceptibility of Mycobacterium leprae: a retrospective analysis of mouse footpad inoculation results from 1983 to 1997.
Sekar B; Elangeswaran N; Jayarama E; Rajendran M; Kumar SS; Vijayaraghavan R; Anandan D; Arunagiri K
Lepr Rev; 2002 Sep; 73(3):239-44. PubMed ID: 12449888
[TBL] [Abstract][Full Text] [Related]
27. Reverse line probe assay for the rapid detection of rifampicin resistance in Mycobacterium leprae.
Sapkota BR; Ranjit C; Macdonald M
Nepal Med Coll J; 2006 Jun; 8(2):122-7. PubMed ID: 17017404
[TBL] [Abstract][Full Text] [Related]
28. Active surveillance of leprosy contacts in country with low prevalence rate.
Kai M; Maeda Y; Maeda S; Fukutomi Y; Kobayashi K; Kashiwabara Y; Makino M; Abbasi MA; Khan MZ; Shah PA
Int J Lepr Other Mycobact Dis; 2004 Mar; 72(1):50-3. PubMed ID: 15217314
[TBL] [Abstract][Full Text] [Related]
29. Mycobacterium leprae is identified in the oral mucosa from paucibacillary and multibacillary leprosy patients.
Morgado de Abreu MA; Roselino AM; Enokihara M; Nonogaki S; Prestes-Carneiro LE; Weckx LL; Alchorne MM
Clin Microbiol Infect; 2014 Jan; 20(1):59-64. PubMed ID: 23473290
[TBL] [Abstract][Full Text] [Related]
30. Study of rifampicin resistance and comparison of dapsone resistance of M. leprae in pre- and post-MDT era.
Gupta UD; Katoch K; Katoch VM
Indian J Lepr; 2009; 81(3):131-4. PubMed ID: 20509341
[TBL] [Abstract][Full Text] [Related]
31. Structural Implications of Mutations Conferring Rifampin Resistance in Mycobacterium leprae.
Vedithi SC; Malhotra S; Das M; Daniel S; Kishore N; George A; Arumugam S; Rajan L; Ebenezer M; Ascher DB; Arnold E; Blundell TL
Sci Rep; 2018 Mar; 8(1):5016. PubMed ID: 29567948
[TBL] [Abstract][Full Text] [Related]
32. Drug resistance in patients with leprosy in the United States.
Williams DL; Lewis C; Sandoval FG; Robbins N; Keas S; Gillis TP; Scollard DM
Clin Infect Dis; 2014 Jan; 58(1):72-3. PubMed ID: 24065328
[TBL] [Abstract][Full Text] [Related]
33. Surveillance of drug resistance in leprosy: 2009.
Wkly Epidemiol Rec; 2010 Jul; 85(29):281. PubMed ID: 20635520
[No Abstract] [Full Text] [Related]
34. [Study of rifampin and dapsone resistance in three patients with recurring leprosy].
Hernández E; Cardona-Castro N; Rodríguez G; Villegas S; Beltrán C; Kimura M; Vissa VD; Gómez Y
Rev Panam Salud Publica; 2008 Feb; 23(2):73-7. PubMed ID: 18371276
[TBL] [Abstract][Full Text] [Related]
35. The activity of rifabutin against Mycobacterium leprae.
Yoder LJ; Jacobson RR; Hastings RC
Lepr Rev; 1991 Sep; 62(3):280-7. PubMed ID: 1665534
[TBL] [Abstract][Full Text] [Related]
36. Drug-resistant M leprae.
Saunderson PR
Clin Dermatol; 2016; 34(1):79-81. PubMed ID: 26773627
[TBL] [Abstract][Full Text] [Related]
37. Report of rpoB mutation in clinically suspected cases of drug resistant leprosy: a study from Eastern India.
Hasanoor Reja AH; Biswas N; Biswas S; Lavania M; Chaitanya VS; Banerjee S; Maha Patra PS; Gupta UD; Patra PK; Sengupta U; Bhattacharya B
Indian J Dermatol Venereol Leprol; 2015; 81(2):155-61. PubMed ID: 25751332
[TBL] [Abstract][Full Text] [Related]
38. Effect of treatment on PCR positivity in multibacillary leprosy patients treated with conventional and newer drugs ofloxacin and minocycline.
Singh HB; Katoch K; Natrajan M; Sharma RK; Gupta UD; Sharma VD; Singh D; Chauhan DS; Srivastava K; Katoch VM
Acta Leprol; 1999; 11(4):179-82. PubMed ID: 10987049
[TBL] [Abstract][Full Text] [Related]
39. Long term follow-up results of 1 year MDT in MB leprosy patients treated with standard MDT + once a month Minocycline and Ofloxacin.
Katoch K; Katoch VM; Natarajan M; Gupta UD; Sharma VD; Singh HB
Indian J Lepr; 2008; 80(4):331-44. PubMed ID: 20329382
[TBL] [Abstract][Full Text] [Related]
40. Primary dapsone resistant Mycobacterium leprae in a non endemic country.
Jamil A; Noor NM; Osman AS; Baseri MM; Muthupalaniappen L
Indian J Dermatol Venereol Leprol; 2013; 79(4):527-9. PubMed ID: 23760326
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
